4,867 results
Search Results
2. An assessment of the quality of vaccination data produced through smart paper technology in The Gambia.
- Author
-
Sowe, Alieu and Gariboldi, Maria Isabella
- Subjects
- *
ELECTRONIC paper , *DATA quality , *MANAGEMENT information systems , *ELECTRONIC equipment - Abstract
MyChild Solution is an innovative Electronic Immunisation Register (EIR) reliant on Smart Paper Technology, thereby eliminating the need for electronic devices and internet connectivity at the point-of-care. The goal of this study is to characterise the quality of routine immunisation data generated using MyChild Solution compared to data obtained through the conventional health management information system (HMIS) used in The Gambia. We used the World Health Organization's (WHO) Data Quality Review (DQR) Toolkit to evaluate MyChild Solution's data quality in the 19 health facilities across two regions implementing MyChild Solution in The Gambia at the time of the evaluation. We evaluated all applicable data quality metrics as well as additional metrics of interest, including the incidence of recording errors, the incidence of incomplete indicator level data, and implausible dates. Where possible, we compared results to those of the conventional HMIS. Both MyChild Solution and the conventional HMIS produced 100% complete and timely data in their reference years. Both systems had no moderate or extreme outliers and showed the expected Penta 1 to Penta 3 dropout direction. However, the proportion of verification factors that are not acceptable was higher in the conventional HMIS. MyChild Solution was found to near perfectly (99.98%) digitise scanned documents. These and other data quality indicators evaluated demonstrate that MyChild Solution produces high quality data with high completeness, timeliness, and consistency compared to the conventional HMIS system. MyChild Solution produces high quality data as per the DQR Toolkit metrics and other metrics of interest of interest. The more internally consitent data produced through MyChild Solution compared to the conventional HMIS demonstrates its potential for supporting data-driven decision-making in immunisation. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
3. Writing a scientific paper—A brief guide for new investigators
- Author
-
Vitse, Caroline L. and Poland, Gregory A.
- Published
- 2017
- Full Text
- View/download PDF
4. White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink
- Author
-
Goddard, Kristin, Panneton, Michelle, Groom, Holly, Plotkin, Stanley A., Orenstein, Walter A., Marcuse, Edgar K., Brookhart, M. Alan, Kulldorff, Martin, Shimabukuro, Tom, McNeil, Michael, Gee, Julianne, Weintraub, Eric, Sukumaran, Lakshmi, Glanz, Jason M., Newcomer, Sophia R., Jackson, Michael L., Omer, Saad B., Bednarczyk, Robert A., Shoup, Jo Ann, DeStefano, Frank, and Daley, Matthew F.
- Published
- 2016
- Full Text
- View/download PDF
5. A paper-based immunoassay to determine HPV vaccination status at the point-of-care
- Author
-
Grant, Benjamin D., Smith, Chelsey A., Castle, Philip E., Scheurer, Michael E., and Richards-Kortum, Rebecca
- Published
- 2016
- Full Text
- View/download PDF
6. The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper
- Author
-
Halsey, Neal A., Talaat, Kawsar R., Greenbaum, Adena, Mensah, Eric, Dudley, Matthew Z., Proveaux, Tina, and Salmon, Daniel A.
- Published
- 2015
- Full Text
- View/download PDF
7. Author response to a Letter to the Editor on "Introductory paper: High dose influenza vaccine".
- Author
-
Diaco M, Yin K, Seet B, and Samson S
- Abstract
Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Mia Diaco reports a relationship with Sanofi Pasteur that includes: employment. Kevin Yin reports a relationship with Sanofi Pasteur that includes: employment. Bruce Seet reports a relationship with Sanofi Pasteur that includes: employment. Sandrine Samson reports a relationship with Sanofi Pasteur that includes: employment.
- Published
- 2021
- Full Text
- View/download PDF
8. Rabies vaccines: WHO position paper, April 2018 – Recommendations.
- Author
-
World Health Organization, null
- Subjects
- *
RABIES vaccines , *PREVENTIVE medicine , *IMMUNOGLOBULINS , *CHOLERA vaccines - Abstract
This article presented the World Health Organization’s (WHO) recommendations on the use of Rabies vaccines excerpted from the Rabies vaccines: WHO position paper – April 2018 published in the Weekly Epidemiological Record [1] This position paper replaces the 2010 WHO position paper on rabies vaccines [2] . It presents new evidence in the field of rabies and the use of rabies vaccines, focussing on programmatic feasibility, simplification of vaccination schedules and improved cost-effectiveness. The recommendations concern the 2 main immunization strategies, namely vaccination for post-exposure prophylaxis and vaccination for pre-exposure prophylaxis. In the context of post-exposure prophylaxis, recommendations are also provided on the use of rabies immunoglobulins. Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence, and to the evidence-to-recommendation tables. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO’s current position on the use of vaccines in the global context. Recommendations on the use of cholera vaccines were discussed by the Strategic Advisory Group of Experts (SAGE) in October 2017; evidence presented at these meetings can be accessed at: http://www.who.int/immunization/sage/meetings/2017/october/presentations_background_docs/en/ . [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
9. Introductory paper: High-dose influenza vaccine.
- Author
-
Diaco M, Chang LJ, Seet B, Robertson CA, Chit A, Mercer M, Greenberg DP, Hollingsworth R, and Samson SI
- Subjects
- Aged, Global Health, Humans, Seasons, Vaccination, Influenza Vaccines, Influenza, Human prevention & control
- Abstract
Seasonal influenza has a significant impact on global public health each year, especially in older adults 65 years of age and above. This paper presents the evolution of high-dose influenza vaccine and the quantity as well as quality of evidence on this vaccine. Its introduces other peer-reviewed manuscripts included in this supplement covering the benefits high-dose influenza vaccine over ten consecutive influenza seasons. The development of the high-dose influenza vaccine represents an important step in the evolution of influenza vaccines, offering an advancement in prevention of influenza and a step in encouraging healthy aging in older adults. A video summary of the article can be accessed via the Supplementary data link at the end of this article., Competing Interests: Declaration of Competing Interest MD, LJC, BS, CR, AC, MM, DPG, RH, and SIS are employees of Sanofi Pasteur., (Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
10. Dengue vaccine: WHO position paper, September 2018 - Recommendations.
- Subjects
- Age Factors, Dengue history, Dengue Vaccines administration & dosage, Global Health, History, 21st Century, Humans, Immunization Schedule, Public Health, Public Health Surveillance, Vaccination, World Health Organization, Dengue prevention & control, Dengue Vaccines immunology, Dengue Virus immunology
- Abstract
This article presents the World Health Organization's (WHO) recommendations on the use of dengue vaccine excerpted from the WHO position paper on dengue vaccine - September 2018, published in the Weekly Epidemiological Record [1]. This position paper replaces the July 2016 WHO position paper concerning the first licensed dengue vaccine, CYD-TDV [2]. The position paper presents new evidence that became available in November 2017. A retrospective analysis of data from clinical trials, using a new serological assay classified trial participants according to their dengue serostatus prior to receipt of the first vaccine dose. The analysis revealed an excess risk of severe dengue in seronegative vaccine recipients compared to seronegative non-vaccinated individuals, while confirming long-term protection in seropositive individuals [3]. The paper provides revised guidance on dengue vaccination strategies from a population health perspective. Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence, and to the evidence-to-recommendation table. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. Recommendations on the use of dengue vaccine CYD-TDV were discussed by SAGE in April 2018; evidence presented at the meeting can be accessed at: http://www.who.int/immunization/sage/meetings/2018/april/presentations_background_docs/en/., (Copyright © 2018 World Health Organization. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
11. Tetanus vaccines: WHO position paper, February 2017 – Recommendations
- Published
- 2018
- Full Text
- View/download PDF
12. BCG vaccine: WHO position paper, February 2018 – Recommendations
- Author
-
World Health Organization
- Published
- 2018
- Full Text
- View/download PDF
13. Cholera vaccine: WHO position paper, August 2017 – Recommendations
- Author
-
World Health Organization
- Published
- 2018
- Full Text
- View/download PDF
14. Diphtheria vaccine: WHO position paper, August 2017 – Recommendations
- Author
-
World Health Organization
- Published
- 2018
- Full Text
- View/download PDF
15. Measles vaccines: WHO position paper, April 2017 – Recommendations.
- Author
-
World Health Organization
- Subjects
- *
VIRAL vaccines , *MEASLES prevention , *HEALTH impact assessment , *PUBLIC health - Abstract
Abstract This article presents the World Health Organization's (WHO) recommendations on the use of measles vaccines excerpted from the WHO position paper on Measles vaccines: WHO position paper – April 2017, published in the Weekly Epidemiological Record [1]. This position paper replaces the 2009 WHO position paper on measles vaccines [2]. The position paper summarizes the most recent developments in the field of measles and includes removal of introduction criteria for the routine second dose of measles-containing vaccine (MCV2), guidance on when to vaccinate infants from 6 months of age, and guidance on re-vaccination of HIV-infected children receiving highly active anti-retroviral therapy (HAART). Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence, and to the evidence-to-recommendation table. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. Recommendations on the use of measles vaccines were discussed by SAGE in November 2013, October 2015 and October 2016; evidence presented at these meetings can be accessed at: www.who.int/immunization/sage/meetings/2013/november/presentations%5fbackground%5fdocs/en/ , www.who.int/immunization/sage/meetings/2015/october/presentations%5fbackground%5fdocs/en/ and www.who.int/immunization/sage/meetings/2016/october/presentations_background_docs/en/. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
16. Human papillomavirus vaccines: WHO position paper, May 2017–Recommendations
- Published
- 2017
- Full Text
- View/download PDF
17. Hepatitis B vaccines: WHO position paper, July 2017 - Recommendations.
- Author
-
World Health Organization
- Subjects
- Health Policy, Hepatitis B Vaccines therapeutic use, Humans, Immunization Schedule, Infant, Public Health, Vaccination, Hepatitis B prevention & control, Hepatitis B Vaccines administration & dosage, Immunization Programs, Practice Guidelines as Topic, World Health Organization
- Abstract
This article presents the World Health Organization's (WHO) recommendations on the use of hepatitis B vaccines excerpted from the Hepatitis B vaccines: WHO position paper, July 2017, published in the Weekly Epidemiological Record (Hepatitis B vaccines, 2017) [1]. This position paper replaces the May 2009 WHO position paper on hepatitis B vaccines (Hepatitis B vaccines, 2009) [2]. The position paper gives updated information on hepatitis B vaccines and their storage, transport and deployment. The recommendations concern the target groups for vaccination and the appropriate schedules. In particular, the recommendations stress the importance of vaccination of all infants at birth as the most effective intervention for the prevention of hepatitis B virus-associated disease worldwide. Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence, and to the evidence-to-recommendation table. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. Recommendations on the use of hepatitis B vaccines were discussed by SAGE in October 2016; evidence presented at these meetings can be accessed at: http://www.who.int/immunization/sage/meetings/2016/October/presentations_background_docs/en/., (Copyright © 2017. Published by Elsevier Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
18. Polio vaccines: WHO position paper, March 2016–recommendations
- Author
-
World Health Organization
- Published
- 2017
- Full Text
- View/download PDF
19. Typhoid vaccines: WHO position paper, March 2018 - Recommendations.
- Author
-
World Health Organization
- Subjects
- Global Health, Health Policy, Humans, Immunization Schedule, Public Health, Salmonella typhi immunology, Typhoid-Paratyphoid Vaccines administration & dosage, Vaccination, Immunization Programs organization & administration, Practice Guidelines as Topic, Typhoid Fever prevention & control, Typhoid-Paratyphoid Vaccines therapeutic use, World Health Organization
- Abstract
This article presented the World Health Organization's (WHO) recommendations on the use of Typhoid vaccines excerpted from the Typhoid vaccines: WHO position paper - March 2018 published in the Weekly Epidemiological Record (World Health Organization, 2018) [1]. This position paper replaces the 2008 WHO position paper on typhoid vaccines (WHO, 2008) [2]. It re-emphasizes the importance of vaccination to control typhoid fever and presents the WHO recommendations on the use of a new generation of typhoid conjugate vaccines. Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence, and to the evidence-to-recommendation tables. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. Recommendations on the use of cholera vaccines were discussed by the Strategic Advisory Group of Experts (SAGE) in October 2017; evidence presented at these meetings can be accessed at: http://www.who.int/immunization/sage/meetings/2017/October/presentations_background_docs/en/., (Copyright © 2018. Published by Elsevier Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
20. Pertussis vaccines: WHO position paper, August 2015—Recommendations
- Published
- 2016
- Full Text
- View/download PDF
21. Malaria vaccine: WHO position paper, January 2016 - Recommendations.
- Subjects
- Humans, Immunization Schedule, Malaria, Falciparum immunology, Malaria, Falciparum parasitology, Pilot Projects, Plasmodium falciparum immunology, Plasmodium falciparum pathogenicity, Practice Guidelines as Topic, World Health Organization, Health Policy, Immunization Programs organization & administration, Malaria Vaccines administration & dosage, Malaria, Falciparum prevention & control, Vaccination methods, Vaccines, Synthetic administration & dosage
- Abstract
This article presents the World Health Organization's (WHO) recommendations on the use of malaria vaccine excerpted from the WHO position paper on malaria vaccine published in the Weekly epidemiological Record in January 2016 [1]. The current document is the first WHO position paper on malaria vaccination and focuses primarily on the available evidence concerning the only malaria vaccine having received a positive regulation assessment from the European Medicines Agency (EMA) [2]. The position paper gives consideration to the epidemiological features of the disease and assesses the potential use of the vaccine for public health benefits. Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence, and to the evidence to recommendation table. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This paper reflects the joint recommendation of the WHO's Strategic Advisory Group of Experts (SAGE) on immunization and the Malaria Policy Advisory Committee (MPAC). These recommendations were discussed by SAGE and MPAC at the October 2015 SAGE meeting. Evidence presented at the meeting can be accessed at http://www.who.int/immunization/sage/previous/en/index.html., (Copyright © 2016 Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
22. WHO position paper, Meningococcal A conjugate vaccine: Updated guidance, February 2015.
- Author
-
World Health Organization
- Subjects
- Child, Preschool, Humans, Immunization Programs legislation & jurisprudence, Immunization Schedule, Infant, Meningitis, Meningococcal immunology, Neisseria meningitidis immunology, Neisseria meningitidis pathogenicity, Practice Guidelines as Topic, Vaccination Coverage legislation & jurisprudence, Vaccines, Conjugate, World Health Organization, Health Policy, Immunization Programs organization & administration, Meningitis, Meningococcal prevention & control, Meningococcal Vaccines administration & dosage, Vaccination, Vaccination Coverage organization & administration
- Abstract
This article presents the World Health Organization's (WHO) updated recommendations on the use of meningococcal vaccines excerpted from the WHO position paper on Meningococcal A conjugate vaccine: updated guidance, February 2015, published in the Weekly Epidemiological Record [1]. A position paper on meningococcal vaccines was published in 2011 and its recommendations remain valid [2]. This update adds to the previous recommendations specifically concerning routine immunization of infants and young children in the African meningitis belt with meningococcal A conjugate vaccine. Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. Recommendations on the use of the Meningococcal A conjugate vaccine were discussed by SAGE in October 2014; evidence presented at these meetings can be accessed at: http://www.who.int/immunization/sage/meetings/2014/october/presentations_background_docs/en/., (Copyright © 2017 World Health Organization. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
23. WHO position on the use of fractional doses - June 2017, addendum to vaccines and vaccination against yellow fever WHO: Position paper - June 2013.
- Author
-
World Health Organization
- Subjects
- Humans, World Health Organization, Vaccination standards, Viral Vaccines immunology, Yellow Fever immunology, Yellow Fever prevention & control, Yellow Fever Vaccine immunology, Yellow Fever Vaccine standards
- Abstract
This article presents the World Health Organization's (WHO) recommendations on the use of fractional doses of yellow fever vaccines excerpted from the "Yellow fever vaccine: WHO position on the use of fractional doses - June 2017, Addendum to Vaccines and vaccination against yellow fever WHO: Position Paper - June 2013″, published in the Weekly Epidemiological Record [1,2]. This addendum to the 2013 position paper pertains specifically to use of fractional dose YF (fYF) vaccination (fractional dose yellow fever vaccination refers to administration of a reduced volume of vaccine dose, which has been reconstituted as usual per manufacturer recommendations) in the context of YF vaccine supply shortages beyond the capacity of the global stockpile. The current WHO position on the use of yellow fever (YF) vaccine is set out in the 2013 WHO position paper on vaccines and vaccination against YF and those recommendations are unchanged. Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence, and to the evidence-to-recommendation table. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. Recommendations on the use of Yellow Fever vaccines were discussed by SAGE in October 2016; evidence presented at these meetings can be accessed at: www.who.int/immunization/sage/meetings/2016/October/presentations_background_docs/en/., (Copyright © 2017. Published by Elsevier Ltd.)
- Published
- 2017
- Full Text
- View/download PDF
24. Dengue vaccine: WHO position paper, July 2016 - recommendations.
- Author
-
World Health Organization
- Subjects
- Dengue epidemiology, Female, Health Policy, Humans, Male, Practice Guidelines as Topic, Public Health, Vaccination, Dengue prevention & control, Dengue Vaccines administration & dosage, Immunization Programs, World Health Organization
- Abstract
This article presents the World Health Organization's (WHO) recommendations on the use of dengue vaccine excerpted from the WHO position paper on dengue vaccine published in the Weekly epidemiological Record in July 2016 (Dengue vaccine: WHO position paper, 2016) [1]. The current document is the first WHO position paper on dengue vaccination and focuses primarily on the available evidence concerning the only dengue vaccine to have been registered by National Regulatory Authorities. The position paper gives consideration to the epidemiological features of the disease and assesses the potential use of the vaccine for public health benefits. Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence, and to the evidence-to-recommendation table. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This paper reflects the recommendations of the WHO's Strategic Advisory Group of Experts (SAGE) on immunization. Recommendations on the use of this dengue vaccine were discussed by SAGE in April 2016; evidence presented at that SAGE meeting can be accessed at: http://www.who.int/immunization/sage/previous/en/index.html., (Copyright © 2016 Elsevier Ltd. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
25. Japanese Encephalitis Vaccines: WHO position paper, February 2015--Recommendations.
- Subjects
- Adolescent, Child, Child, Preschool, Female, Global Health, Humans, Infant, Japanese Encephalitis Vaccines adverse effects, Male, Pregnancy, World Health Organization, Encephalitis, Japanese epidemiology, Encephalitis, Japanese prevention & control, Guidelines as Topic, Japanese Encephalitis Vaccines administration & dosage, Japanese Encephalitis Vaccines immunology
- Abstract
This article presents the World Health Organization's (WHO) recommendations on the use of Japanese Encephalitis (JE) vaccines excerpted from the WHO position paper on Japanese Encephalitis vaccines recently published in the Weekly Epidemiological Record [1]. This updated position paper on JE vaccines replaces the 2006 position paper on this subject [2]; it focuses on new information concerning the availability, safety, immunogenicity and effectiveness of JE vaccines and the duration of protection they confer. Recent data on global prevalence and burden of disease caused by JE and cost-effectiveness considerations regarding JE vaccination are also summarized. Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This paper reflects the recommendations of WHO's Strategic Advisory Group of Experts (SAGE) on immunization. These recommendations were discussed by SAGE at its October 2014 meeting. Evidence presented at the meeting can be accessed at http://www.who.int/immunization/sage/previous/en/index.html., (Copyright © 2015 The World Health Organization. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
26. Hepatitis E vaccine: WHO position paper, May 2015--Recommendations.
- Subjects
- Adolescent, Adult, Female, Global Health, Humans, Male, Middle Aged, Viral Hepatitis Vaccines adverse effects, World Health Organization, Young Adult, Guidelines as Topic, Hepatitis E epidemiology, Hepatitis E prevention & control, Viral Hepatitis Vaccines administration & dosage, Viral Hepatitis Vaccines immunology
- Abstract
This article presents the World Health Organization's (WHO) recommendations on the use of hepatitis E vaccine excerpted from the WHO position paper on hepatitis E vaccines - May 2015 recently published in the Weekly Epidemiological Record [1]. The current document is the first WHO position paper on hepatitis E vaccination and focuses primarily on the available evidence concerning the only hepatitis E vaccine that is currently licensed. The position paper gives consideration to the epidemiological features of the disease and assesses the use of the vaccine for public health benefits. Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This paper reflects the recommendations of WHO's Strategic Advisory Group of Experts (SAGE) on immunization. These recommendations were discussed by SAGE at its October 2014 meeting. Evidence presented at the meeting can be accessed at http://www.who.int/immunization/sage/previous/en/index.html., (Copyright © 2015 The World Health Organization. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
27. Varicella and herpes zoster vaccines: WHO position paper, June 2014--Recommendations.
- Subjects
- Humans, World Health Organization, Chickenpox epidemiology, Chickenpox prevention & control, Chickenpox Vaccine administration & dosage, Chickenpox Vaccine immunology, Guidelines as Topic, Herpes Zoster epidemiology, Herpes Zoster prevention & control
- Abstract
This article presents the World Health Organization's (WHO) recommendations for the use of varicella and herpes zoster vaccination from the WHO position paper on varicella and herpes zoster vaccines - June 2014, published in the Weekly Epidemiological Record [1]. This position paper summarizes the WHO position on the use of varicella and herpes zoster vaccines. The current document replaces the position paper on the use of varicella vaccines published in 1998 [2]. Footnotes to this paper provide a number of core references. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This paper reflects the recommendations of WHO's Strategic Advisory Group of Experts (SAGE) on immunization. These recommendations were discussed by SAGE at its April 2014 meeting. Evidence presented at the meeting can be accessed at http://www.who.int/immunization/sage/previous/en/index.html., (Copyright © 2015 The World Health Organization. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
28. Human papillomavirus vaccines: WHO position paper, October 2014-Recommendations.
- Subjects
- Female, Humans, Papillomavirus Infections complications, World Health Organization, Immunization Schedule, Papillomavirus Infections epidemiology, Papillomavirus Infections prevention & control, Papillomavirus Vaccines administration & dosage, Papillomavirus Vaccines immunology
- Abstract
This article presents the World Health Organization's (WHO) recommendations for the use of vaccines against diseases caused by human papillomaviruses (HPV) from the WHO position paper on Human papillomavirus vaccines: WHO position paper - October 2014, recently published in the Weekly Epidemiological Record [1]. This position paper summarizes the most recent developments in the field of HPV vaccines and the WHO position on HPV vaccine schedules in females. This document replaces the first WHO position paper on vaccines against diseases caused by HPV published in 2009 [2]. Footnotes to this paper provide a number of core references. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This paper reflects the recommendations of WHO's Strategic Advisory Group of Experts (SAGE) on immunization. These recommendations were discussed by SAGE at its April 2014 meeting. Evidence presented at the meeting can be accessed at http://www.who.int/immunization/sage/previous/en/index.html., (Copyright © 2015 The Author. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
29. Vaccines and vaccination against yellow fever: WHO Position Paper, June 2013--recommendations.
- Subjects
- Humans, Practice Guidelines as Topic, Vaccination adverse effects, World Health Organization, Yellow Fever Vaccine administration & dosage, Yellow Fever Vaccine adverse effects, Vaccination methods, Yellow Fever prevention & control, Yellow Fever Vaccine immunology
- Abstract
This article presents the World Health Organizations (WHO) evidence and recommendations for the use of yellow fever (YF) vaccination from "Vaccines and vaccination against yellow fever: WHO Position Paper - June 2013" published in the Weekly Epidemiological Record. This position paper summarizes the WHO position on the use of YF vaccination, in particular that a single dose of YF vaccine is sufficient to confer sustained life-long protective immunity against YF disease. A booster dose is not necessary. The current document replaces the position paper on the use of yellow fever vaccines and vaccination published in 2003. Footnotes to this paper provide a number of core references. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This paper reflects the recommendations of WHO's Strategic Advisory Group of Experts (SAGE) on immunization. These recommendations were discussed by SAGE at its April 2013 meeting. Evidence presented at the meeting can be accessed at http://www.who.int/immunization/sage/previous/en/index.html., (Copyright © 2014. Published by Elsevier Ltd.)
- Published
- 2015
- Full Text
- View/download PDF
30. Reducing pain at the time of vaccination: WHO position paper, September 2015-Recommendations.
- Subjects
- Humans, Practice Guidelines as Topic, Public Health, World Health Organization, Pain prevention & control, Pain Management methods, Vaccination adverse effects
- Abstract
This article presents the World Health Organization's (WHO) recommendations for pain mitigation at the time of vaccination from the WHO position paper on reducing pain at the time of vaccination: WHO position paper-September 2015, recently published in the Weekly Epidemiological Record [1]. This position paper summarizes the evidence and integrates information pertaining to the reduction of pain, distress and fear during immunization across all age groups. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact, and on vaccination-related policy questions particularly concerning the use of vaccines in large-scale immunization programmes. They summarize essential background information and conclude with the current WHO position. This position paper addresses a cross-cutting issue which is relevant for all injectable vaccines and reflects the recommendations of WHO's Strategic Advisory Group of Experts (SAGE) on immunization. These recommendations were discussed by SAGE at its April 2015 meeting. The evidence presented at the meetings can be accessed at http://www.who.int/immunization/sage/previous/en/index.html., (Copyright © 2016 World Health Organization. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
31. New recommendations to prevent pain during immunizations: WHO position paper - September 2015.
- Author
-
Pottie K, Siu W, and Duclos P
- Subjects
- Humans, Pain prevention & control, Immunization, World Health Organization
- Published
- 2016
- Full Text
- View/download PDF
32. White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink.
- Author
-
Glanz JM, Newcomer SR, Jackson ML, Omer SB, Bednarczyk RA, Shoup JA, DeStefano F, and Daley MF
- Subjects
- Centers for Disease Control and Prevention, U.S., Humans, Immunization methods, Infant, Safety, United States, Adverse Drug Reaction Reporting Systems, Databases, Pharmaceutical, Immunization Schedule, Vaccines adverse effects, Vaccines therapeutic use
- Abstract
While the large majority of parents in the U.S. vaccinate their children according to the recommended immunization schedule, some parents have refused or delayed vaccinating, often citing safety concerns. In response to public concern, the U.S. Institute of Medicine (IOM) evaluated existing research regarding the safety of the recommended immunization schedule. The IOM concluded that although available evidence strongly supported the safety of the currently recommended schedule as a whole, additional observational research was warranted to compare health outcomes between fully vaccinated children and those on a delayed or alternative schedule. In addition, the IOM identified the Vaccine Safety Datalink (VSD) as an important resource for conducting this research. Guided by the IOM findings, the Centers for Disease Control and Prevention (CDC) commissioned a White Paper to assess how the VSD could be used to study the safety of the childhood immunization schedule. Guided by subject matter expert engagement, the resulting White Paper outlines a 4 stage approach for identifying exposure groups of undervaccinated children, presents a list of health outcomes of highest priority to examine in this context, and describes various study designs and statistical methods that could be used to analyze the safety of the schedule. While it appears feasible to study the safety of the recommended immunization schedule in settings such as the VSD, these studies will be inherently complex, and as with all observational studies, will need to carefully address issues of confounding and bias. In light of these considerations, decisions about conducting studies of the safety of the schedule will also need to assess epidemiological evidence of potential adverse events that could be related to the schedule, the biological plausibility of an association between an adverse event and the schedule, and public concern about the safety of the schedule., (Copyright © 2015 Elsevier Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
33. Polio vaccines: WHO position paper, January 2014--recommendations.
- Subjects
- Humans, Immunization Schedule, Health Policy, Poliovirus Vaccines, Vaccination standards, World Health Organization
- Abstract
This article presents the World Health Organizations (WHO) evidence and recommendations for the use of polio vaccination from the WHO position paper on polio vaccines - January 2014 recently published in the Weekly Epidemiological Record [1]. This position paper summarizes the WHO position on the introduction of at least one dose of inactivated polio vaccine (IPV) into routine immunization schedules as a strategy to mitigate the potential risk of re-emergence of type 2 polio following the withdrawal of Sabin type 2 strains from oral polio vaccine (OPV). The current document replaces the position paper on the use of polio vaccines published in 2010 [2]. Footnotes to this paper provide a number of core references. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This paper reflects the recommendations of WHO's Strategic Advisory Group of Experts (SAGE) on immunization. These recommendations were discussed by SAGE at its November 2013 meeting. Evidence presented at the meeting can be accessed at http://www.who.int/immunization/sage/previous/en/index.html., (Copyright © 2014 World Health Organization. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
34. Haemophilus influenzae type b (Hib) Vaccination WHO position paper: July 2013-Recommendations.
- Subjects
- Global Health, Haemophilus Infections epidemiology, Haemophilus influenzae type b immunology, Health Policy, Humans, Immunization Programs, World Health Organization, Guidelines as Topic, Haemophilus Infections microbiology, Haemophilus Infections prevention & control, Haemophilus Vaccines administration & dosage, Haemophilus Vaccines immunology, Haemophilus influenzae type b isolation & purification, Vaccination methods
- Abstract
This article presents the World Health Organizations (WHO) evidence and recommendations for the use of Haemophilus influenzae type b vaccination from the WHO position paper on H. influenzae type b (Hib) Vaccination - July 2013 recently published in the Weekly Epidemiological Record [1]. This position paper summarizes the WHO position on the inclusion of Hib vaccines in all national immunization programmes, recent developments in the field and the potential of different Hib immunization schedules to further reduce morbidity and mortality. The current document replaces the position paper on the use of Hib vaccines published in 2006 [2]. Footnotes to this paper provide a number of core references. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This paper reflects the recommendations of WHO's Strategic Advisory Group of Experts (SAGE) on immunization. These recommendations were discussed by SAGE at its April 2013 meeting. Evidence presented at the meeting can be accessed at http://www.who.int/immunization/sage/previous/en/index.html., (Copyright © 2013. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
35. Rabies vaccines: WHO position paper—Recommendations
- Subjects
- *
RABIES vaccines , *RABIES virus , *CELL culture , *HEALTH policy , *PUBLIC health , *HEALTH programs , *EXPERT evidence , *IMMUNIZATION - Abstract
Abstract: This article presents the WHO recommendations on the use of rabies vaccines excerpted from the recently published Rabies vaccines: WHO position paper. This document replaces the WHO position paper entitled Rabies vaccines WHO position paper published in the Weekly Epidemiological Record in December 2007. Footnotes to this paper provide a limited number of core references; their abstracts as well as a more comprehensive list of references may be found at http://www.who.int/immunization/documents/positionpapers/en/index.html. Grading tables which assess the quality of scientific evidence for key conclusions are also available through this link and are referenced in the position paper. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO''s current position on the use of vaccines in the global context. This updated paper reflects the recent recommendations of WHO''s Strategic Advisory Group of Experts on immunization, or SAGE. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
36. Hepatitis E vaccine: WHO position paper, May 2015 – Recommendations
- Author
-
WHO
- Published
- 2016
- Full Text
- View/download PDF
37. Japanese Encephalitis Vaccines: WHO position paper, February 2015 – Recommendations
- Author
-
WHO
- Published
- 2016
- Full Text
- View/download PDF
38. Rotavirus vaccines WHO position paper: January 2013 - Recommendations.
- Subjects
- Global Health, Health Policy, Humans, Immunization Programs, Rotavirus Infections epidemiology, World Health Organization, Guidelines as Topic, Rotavirus Infections prevention & control, Rotavirus Vaccines administration & dosage, Rotavirus Vaccines immunology, Vaccination methods
- Abstract
This article presents the World Health Organizations (WHO) evidence and recommendations for the use of rotavirus vaccination from the WHO position paper on rotavirus vaccines - January 2013 recently published in the Weekly Epidemiological Record [1]. This position paper summarizes the WHO position on the inclusion of rotavirus vaccines in all national immunization programmes and recent developments in the field, in particular the potential of rotavirus vaccines to further reduce mortality by employing more flexible immunization schedules. The current document replaces the position paper on the use of rotavirus vaccines published in 2007 [2]. Footnotes to this paper provide a number of core references. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This paper reflects the recommendations of WHO's Strategic Advisory Group of Experts (SAGE) on immunization. These recommendations were discussed by SAGE at its April 2012 meeting. Evidence presented at the meeting can be accessed at http://www.who.int/immunization/sage/previous/en/index.html., (Copyright © 2013 World Health Organization. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
39. Vaccines and vaccination against yellow fever: WHO Position Paper, June 2013—Recommendations
- Author
-
WHO
- Published
- 2015
- Full Text
- View/download PDF
40. WHO position paper on hepatitis A vaccines: June 2012-recommendations.
- Subjects
- Health Policy, Humans, Public Health standards, Vaccination standards, World Health Organization, Hepatitis A Vaccines immunology, Hepatitis A Vaccines standards, Immunization standards, Immunization Programs standards
- Abstract
This article presents the World Health Organizations (WHO) recommendations onthe use of hepatitis A vaccine excerpted from the WHO position paper on hepatitis A vaccines - June 2012 recently published in the Weekly Epidemiological Record [1]. The current document replaces the position paper on the use of hepatitis A vaccines published in 2000 [2] and incorporates the most recent developments in the field with particular consideration to changes in the epidemiological features of hepatitis A infection in several countries, increased supply of hepatitis A vaccines, and new evidence on their public health benefits. Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of scientific evidence for a few key conclusions. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This paper reflects the recommendations of WHO's Strategic Advisory Group of Experts (SAGE) on immunization. These recommendations were discussed by SAGE at its November 2011 and April 2012 meetings. Evidence presented at these meetings can be accessed at http://www.who.int/immunization/sage/previous/en/index.html., (Copyright © 2012. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
41. Pneumococcal vaccines WHO position paper - 2012 - recommendations.
- Subjects
- Humans, Immunization Schedule, Sentinel Surveillance, Vaccines, Conjugate, Guidelines as Topic, Immunization Programs, Pneumococcal Infections prevention & control, Pneumococcal Vaccines, World Health Organization
- Abstract
This article presents the World Health Organization (WHO) recommendations on the use of pneumococcal vaccines excerpted from the Pneumococcal vaccines WHO position paper - 2012 recently published in the Weekly Epidemiological Record. The current document replaces the position paper on the use 7-valent pneumococcal conjugate vaccine published in 2007. Incorporating the most recent developments in the field of pneumococcal vaccines this position paper focuses on the currently available 10-valent and 13-valent conjugate vaccines and their introduction and use in national immunization programmes. It also deals with the 23-valent polysaccharide vaccine, though in less detail than provided in the April 2008 position paper which remains valid. Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of scientific evidence for a few key conclusions. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines worldwide. This paper reflects the recommendations of the WHO's Strategic Advisory Group of Experts (SAGE) on immunization. Recommendations on the use of pneumococcal vaccines were discussed by SAGE at its meetings in November 2006 (conjugate vaccine) and April 2008 (polysaccharide vaccine) and most recently in November 2011. Evidence presented at these meetings can be accessed at http://www.who.int/immunization/sage/previous/en/index.html., (Copyright © 2012. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
42. Polio vaccines: WHO position paper, January 2014 – Recommendations
- Author
-
WHO
- Published
- 2014
- Full Text
- View/download PDF
43. Vaccines against tick-borne encephalitis: WHO position paper--recommendations.
- Author
-
Who Publication
- Subjects
- Guidelines as Topic, Humans, Immunization Programs, Immunization, Secondary, Vaccination standards, Viral Vaccines immunology, Encephalitis, Tick-Borne prevention & control, Viral Vaccines administration & dosage, World Health Organization
- Abstract
This article presents the WHO recommendations on the use of vaccines against tick-borne encephalitis excerpted from the recently published Vaccines against tick-borne encephalitis: WHO position paper. This is the first WHO position paper on the use of tick-borne encephalitis. It was published in the Weekly Epidemiological Record in June 2011. In this paper, footnotes provide a limited number of core references including references to grading tables that assess the quality of scientific evidence for a few key conclusions; a more comprehensive list of references is offered in the Background document on vaccines and vaccination against tick-borne encephalitis available at http://www.who.int/immunization/sage/6_TBE_backgr_18_Mar_net_apr_2011.pdf. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This paper reflects the recommendations of WHO's Strategic Advisory Group of Experts (SAGE) on immunization. These recommendations were discussed by SAGE at its April 2011 meeting. Evidence presented at the meeting can be accessed at http://www.who.int/immunization/sage/previous/en/index.html., (Copyright © 2011. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
44. Rubella vaccines: WHO position paper--recommendations.
- Author
-
Who Publication
- Subjects
- Humans, Immunization Schedule, Mass Vaccination, Health Policy, Rubella prevention & control, Rubella Vaccine administration & dosage, World Health Organization
- Published
- 2011
- Full Text
- View/download PDF
45. Pertussis vaccines: WHO position paper--recommendations.
- Subjects
- Humans, Mass Vaccination methods, Vaccines, Combined administration & dosage, Vaccines, Combined immunology, World Health Organization, Pertussis Vaccine administration & dosage, Pertussis Vaccine immunology, Whooping Cough epidemiology, Whooping Cough prevention & control
- Abstract
This article presents the WHO recommendations on the use of pertussis vaccines excerpted from the recently published Pertussis vaccines: WHO position paper. This document replaces the WHO position paper entitled Pertussis vaccines: WHO position paper published in the Weekly Epidemiological Record in January 2005. Footnotes to this paper provide a limited number of core references; their abstracts as well as a more comprehensive list of references may be found at http://www.who.int/immunization/documents/positionpapers/en/index.html. Grading tables which assess the quality of scientific evidence for key conclusions are also available through this link and are referenced in the position paper. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This updated paper reflects the recent recommendations of WHO's Strategic Advisory Group of Experts on immunization, or SAGE., (Copyright © 2011. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
46. Polio vaccines and polio immunization in the pre-eradication era: WHO position paper--recommendations.
- Subjects
- Health Policy, Humans, Immunization Programs, Immunization Schedule, Travel, Poliomyelitis prevention & control, Poliovirus Vaccines, World Health Organization
- Abstract
This article presents the WHO recommendations on the use of polio vaccines excerpted from the recently published Polio vaccines and polio immunization in the pre-eradication era: WHO position paper. This document replaces the WHO position paper entitled Introduction of inactivated poliovirus vaccine into oral poliovirus vaccine-using countries published in the Weekly Epidemiological Record in July 2003. Footnotes to this paper provide a limited number of core references; their abstracts as well as a more comprehensive list of references may be found at http://www.who.int/immunization/documents/positionpapers/en/index.html. Grading tables which assess the quality of scientific evidence for key conclusions are also available through this link and are referenced in the position paper. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This updated paper reflects the recent recommendations of WHO's Strategic Advisory Group of Experts on immunization, or SAGE., (Copyright © 2010. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
47. Cholera vaccines: WHO position paper-Recommendations.
- Subjects
- Cholera epidemiology, Cholera microbiology, Disease Outbreaks, Endemic Diseases, Humans, Immunization Programs, Population Surveillance, World Health Organization, Cholera prevention & control, Cholera Vaccines
- Abstract
This article presents the WHO recommendations on the use of cholera vaccines excerpted from the recently published Cholera vaccines: WHO position paper. This document replaces the WHO position paper on Cholera vaccines published in the Weekly Epidemiological Record in April 2001. Footnotes to this paper provide a limited number of core references; their abstracts as well as a more comprehensive list of references may be found at http://www.who.int/immunization/documents/positionpapers/en/index.html. Grading tables which assess the quality of scientific evidence for key conclusions are also available through this link and are referenced in the position paper. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This updated paper reflects the recent recommendations of WHO's Strategic Advisory Group of Experts on immunization (SAGE)., (Copyright 2010. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
48. Two adult vaccination survey papers.
- Author
-
Lazarsfeld R and Cavallario S
- Subjects
- Bias, Humans, Data Collection standards, Vaccination statistics & numerical data
- Published
- 2010
- Full Text
- View/download PDF
49. Fear, misinformation, and innumerates: how the Wakefield paper, the press, and advocacy groups damaged the public health.
- Author
-
Poland GA and Spier R
- Subjects
- Communication, Communications Media, Humans, Autistic Disorder epidemiology, Health Knowledge, Attitudes, Practice, Measles-Mumps-Rubella Vaccine adverse effects, Patient Acceptance of Health Care
- Published
- 2010
- Full Text
- View/download PDF
50. Hepatitis B vaccines: WHO position paper--recommendations.
- Subjects
- Humans, World Health Organization, Health Planning Guidelines, Hepatitis B epidemiology, Hepatitis B prevention & control, Hepatitis B Vaccines immunology, Hepatitis B Vaccines therapeutic use
- Abstract
This article presents the WHO recommendations on the use of hepatitis B vaccines excerpted from the recently published Hepatitis B vaccines: WHO position paper. This document replaces the WHO position paper on hepatitis B vaccines published in the Weekly Epidemiological Record in July 2004. Footnotes to this paper provide a limited number of core references; their abstracts as well as a more comprehensive list of references may be found at http://www.who.int/immunization/documents/positionpapers/en/index.html. Grading tables assessing the level of scientific evidence are also available through this link and are referenced in the position paper. In accordance with its mandate to provide guidance to Member States on health-policy matters, WHO is issuing a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with the current WHO position concerning their use in the global context. This updated paper reflects the recent recommendations of WHO's strategic Advisory Group of experts on immunization.
- Published
- 2010
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.